Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH (2017) Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cellular Infect Microbiol 7:55. https://doi.org/10.3389/fcimb.2017.00055

Article  CAS  Google Scholar 

Rice LB (2010) Progress and challenges in implementing the research on ESKAPE pathogens. Infect Control Hosp Epidemiol 31:S7–S10. https://doi.org/10.1086/655995

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention. (2019). Antibiotic resistance threats in the United States, 2019. US Department of Health and Human Services, Centres for Disease Control and Prevention.https://www.cdc.gov/antimicrobial-resistance/data-research/threats/index.html

Greene C, Vadlamudi G, Newton D, Foxman B, Xi C (2016) The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control 44(5):e65–e71. https://doi.org/10.1016/j.ajic.2015.12.012

Article  CAS  PubMed  Google Scholar 

Jeannot K, Bolard A, Plesiat P (2017) Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents 49(5):526–535. https://doi.org/10.1016/j.ijantimicag.2016.11.029

Article  CAS  PubMed  Google Scholar 

El-Sayed Ahmed MAEG, Zhong LL, Shen C, Yang Y, Doi Y, Tian GB (2020) Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019). Emerg Microbes Infect 9(1):868–885. https://doi.org/10.1080/22221751.2020.1754133

Article  CAS  PubMed  Google Scholar 

Barati H, Fekrirad Z, Nadoushan MJ, Rasooli I (2024) Anti-OmpA antibodies as potential inhibitors of Acinetobacter baumannii biofilm formation, adherence to, and proliferation in A549 human alveolar epithelial cells. Microb Pathog 186:106473. https://doi.org/10.1016/j.micpath.2023.106473

Article  CAS  PubMed  Google Scholar 

Ramoul A, Loucif L, Bakour S, Amiri S, Dekhil M, Rolain JM (2016) Co-occurrence of blaNDM-1 with blaOXA-23 or blaOXA-58 in clinical multidrug-resistant Acinetobacter baumannii isolates in Algeria. J Global Antimicrob Resist 6:136–141. https://doi.org/10.1016/j.jgar.2016.05.003

Article  Google Scholar 

Bakour S, Olaitan AO, Ammari H, Touati A, Saoudi S, Saoudi K, Rolain JM (2015) Emergence of colistin-and carbapenem-resistant Acinetobacter baumannii ST2 clinical isolate in Algeria: first case report. Microb Drug Resist 21(3):279–285. https://doi.org/10.1089/mdr.2014.0214

Article  CAS  PubMed  Google Scholar 

World Health Organization. (2016). Central Asian and Eastern European Surveillance of Antimicrobial Resistance: annual report 2016. https://www.who.int/europe/groups/central-asian-and-european-surveillance-of-antimicrobial-resistance-(caesar)

Hsu LY, Apisarnthanarak A, Khan E, Suwantarat N, Ghafur A, Tambyah PA (2017) Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in south and Southeast Asia. Clin Microbiol Rev 30(1):1–22. https://doi.org/10.1128/cmr.00042-16

Article  PubMed  Google Scholar 

Chen CH, Wu PH, Lu MC, Ho MW, Hsueh PR (2023) Geographic patterns of carbapenem-resistant, multi-drug-resistant and difficult-to-treat Acinetobacter baumannii in the Asia-Pacific region: results from the antimicrobial testing leadership and surveillance (ATLAS) program, 2020. Int J Antimicrob Agents 61(2):106707. https://doi.org/10.1016/j.ijantimicag.2022.106707

Article  CAS  PubMed  Google Scholar 

D’Arezzo S, Principe L, Capone A, Petrosillo N, Petrucca A, Visca P (2011) Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother 66(1):54–61. https://doi.org/10.1093/jac/dkq407

Article  CAS  PubMed  Google Scholar 

Adams MD, Wright MS, Karichu JK, Venepally P, Fouts DE, Chan AP, Richter SS, Jacobs MR, Bonomo RA (2019) Rapid replacement of Acinetobacter baumannii strains accompanied by changes in Lipooligosaccharide Loci and resistance gene repertoire. MBio 10(2):e00356-e419. https://doi.org/10.1128/mBio.00356-19

Article  CAS  PubMed  Google Scholar 

Karthikeyan K, Thirunarayan MA, Krishnan P (2010) Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother 65(10):2253–2254. https://doi.org/10.1093/jac/dkq273

Article  CAS  PubMed  Google Scholar 

Gupta V, Garg R, Garg S, Chander J, Attri AK (2013) Coexistence of extended spectrum beta-lactamases, AmpC beta-lactamases and metallo-beta-lactamases in Acinetobacter baumannii from burns patients: a report from a tertiary care centre of India. Ann Burns Fire Disasters 26(4):189–192

CAS  PubMed  Google Scholar 

Bouvet PJM, Grimont PAD (1987) Identification and biotyping of clinical isolates of Acinetobacter. Annales de l’Institut Pasteur/Microbiologie. Elsevier, pp 569–578

Google Scholar 

Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, Prashanth K (2008) Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Ind J Med Microbiol 26(4):333–337. https://doi.org/10.1016/S0255-0857(21)01809-0

Article  Google Scholar 

Clinical and Laboratory Standards Institute (CLSI). (2021). Performance standards for antimicrobial susceptibility testing. CLSI document M100. 31st ed 2021, Clinical and Laboratory Standards Institute, Wayne, PA.

The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters (2022). Version 12.0, 2022. http://www.eucast.org.

Zeighami H, Valadkhani F, Shapouri R, Samadi E, Haghi F (2019) Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. BMC Infect Dis 19:1–9. https://doi.org/10.1186/s12879-019-4272-0

Article  CAS  Google Scholar 

Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281

Article  CAS  PubMed  Google Scholar 

Walia K, Madhumathi J, Veeraraghavan B, Chakrabarti A, Kapil A, Ray P, Singh H, Sistla S, Ohri VC (2019) Establishing antimicrobial resistance surveillance & research network in India: journey so far. Ind J Med Res 149(2):164–179

Article  Google Scholar 

Karuna T, Gupta A, Vyas A, Kumar S, Sampath A, Goel P, Shukla P, Mishra V, Sharma S, Chakraborty S, Jaiswal SP (2023) Changing trends in antimicrobial susceptibility patterns of bloodstream infection (BSI) in secondary care hospitals of India. Cureus. https://doi.org/10.7759/cureus.37800

Article  PubMed  PubMed Central  Google Scholar 

Saranathan R, Kumari R, Kalaivani R, Suresh S, Rani A, Purty S, Prashanth K (2017) Detection of IS Aba1 in association with a novel allelic variant of the β-lactamase ADC-82 and class D β-lactamase genes mediating carbapenem resistance among the clinical isolates of MDR A. baumannii. J Med Microbiol 66(2):103–111. https://doi.org/10.1099/jmm.0.000395

Article  PubMed  Google Scholar 

Chapartegui-González I, Lázaro-Díez M, Bravo Z, Navas J, Icardo JM, Ramos-Vivas J (2018) Acinetobacter baumannii maintains its virulence after long-time starvation. PLoS ONE 13(8):e0201961. https://doi.org/10.1371/journal.pone.0201961

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nie L, Lv Y, Yuan M, Hu X, Nie T, Yang X, Li G, Pang J, Zhang J, Li C, Wang X (2014) Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing China. Acta Pharmaceutica Sinica B 4(4):295–300

Article  PubMed  PubMed Central  Google Scholar 

Upadhyay S, Khyriem AB, Bhattacharya P, Bhattacharjee A, Joshi SR (2018) High-level aminoglycoside resistance in Acinetobacter baumannii recovered from intensive care unit patients in Northeastern India. Ind J Med Microbiol 36(1):43–48. https://doi.org/10.4103/ijmm.IJMM_17_225

Article  Google Scholar 

Raible KM, Sen B, Law N, Bias TE, Emery CL, Ehrlich GD, Joshi SG (2017) Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob 16:1–10. https://doi.org/10.1186/s12941-017-0248-3

Article  CAS  Google Scholar 

Agoba EE, Govinden U, Peer AKC, Osei Sekyere J, Essack SY (2018) IS Aba1 regulated OXA-23 carbapenem resistance in Acinetobacter baumannii strains in Durban, South Africa. Microbial Drug Res 24(9):1289–1295. https://doi.org/10.1089/mdr.2017.0172

Article  CAS  Google Scholar 

Karah N, Khalid F, Wai SN, Uhlin BE, Ahmad I (2020) Molecular epidemiology and antimicrobial resistance features of Acinetobacter baumannii clinical isolates from Pakistan. Ann Clin Microbiol Antimicrob 19:1–13. https://doi.org/10.1186/s12941-019-0344-7

Article  CAS  Google Scholar 

Rynga D, Shariff M, Deb M (2015) Phenotypic and molecular characterization of clinical isolates of Acinetobacter baumannii isolated from Delhi, India. Ann Clin Microbiol Antimicrob 14:1–8. https://doi.org/10.1186/s12941-015-0101-5

Article  CAS  Google Scholar 

Khuntayaporn P, Kanathum P, Houngsaitong J, Montakantikul P, Thirapanmethee K, Chomnawang MT (2021) Predominance of international clone 2 multidrug-resistant Acineto